SLEEVE ELEMENT TO BE PLACED ON A NECK OF A PROSTHETIC HIP OR SHOULDER IMPLANT
20220249235 ยท 2022-08-11
Inventors
- Joannes Jacobus VERLAAN (Zeist, NL)
- Bas Jeroen OOSTERMAN (Zeist, NL)
- Floris Rudolf Van Tol (Austerlitz, NL)
- Jasper Gerard STEVERINK (Austerlitz, NL)
Cpc classification
A61F2002/30064
HUMAN NECESSITIES
A61F2002/3007
HUMAN NECESSITIES
A61F2002/30677
HUMAN NECESSITIES
A61F2/30734
HUMAN NECESSITIES
A61F2002/30062
HUMAN NECESSITIES
A61F2002/30014
HUMAN NECESSITIES
International classification
Abstract
The invention provides a sleeve element (1) to be placed on a neck (53) of a prosthetic hip (51) or shoulder implant, wherein the sleeve element is made of a biodegradable elastically deformable material comprising a medical active agent to be released from the sleeve element. The sleeve element may comprise a longitudinal channel (2) and a longitudinal slit (3) extending over the length of the longitudinal channel and between the longitudinal channel and an outer surface of the sleeve element, wherein the sleeve element is elastically deformable between a closed state and an opened state, wherein a width of the longitudinal slit in the opened state is larger than the width of the longitudinal slit in the closed state. The invention also provides a prosthetic kit, comprising a prosthetic hip or shoulder implant having a neck, and the above sleeve element.
Claims
1. A sleeve element to be placed on a neck of a prosthetic hip or shoulder implant, wherein the sleeve element is made of a biodegradable, elastically deformable material comprising one or more medical active agents.
2. The sleeve element of claim 1, wherein the elastic modulus of the biodegradable, elastically deformable material is between 1 kPa and 1 MPa.
3. The sleeve element of claim 1, wherein the sleeve element is free of fixation elements to fixate the sleeve element to the neck of the prosthesis.
4. The sleeve element of claim 1, wherein the sleeve element has a compressive strain of at least 5% at the elastic limit of the elastically deformable material in a direction in which a compressive force is exerted on the elastically deformable material.
5. The sleeve element of claim 1, wherein the biodegradable elastically deformable material comprises a main body and a coating coated on at least a part of the surface the main body, wherein the medical active agent is comprised in the main body, wherein the coating comprises a coating material and the main body comprises a main body material, wherein the coating material is stiffer than the main body material.
6. The sleeve element of claim 1, wherein the sleeve element comprises a longitudinal channel and a longitudinal slit extending over the length of the longitudinal channel and between the longitudinal channel and an outer surface of the sleeve element, wherein the sleeve element is elastically deformable between a closed state and an opened state, wherein a width of the longitudinal slit in the opened state is larger than the width of the longitudinal slit in the closed state.
7. The sleeve element of claim 6, wherein the sleeve element in the closed state is substantially non-deformed and in the opened state the sleeve element is elastically deformed.
8. The sleeve element of claim 6, wherein the sleeve element comprises a closure device to hold the sleeve element in the closed state.
9. The sleeve element according to claim 6, wherein the longitudinal slit is formed between a first longitudinal edge of the sleeve element and a second longitudinal edge of the sleeve element, wherein the closure device comprises a snap fit connection between the first longitudinal edge and the second longitudinal edge.
10. The sleeve element according to claim 9, wherein the closure device comprises a closure element that can be arranged around the sleeve element.
11. The sleeve element of claim 1, wherein the sleeve element comprises a longitudinal channel defined by a continuous ring shape around the longitudinal channel.
12. The sleeve element of claim 1, wherein the sleeve element comprises one or more stiffening elements that bias the sleeve element to the closed state.
13. The sleeve element of claim 12, wherein the one or more stiffening elements comprise one or more elastically deformable ribs arranged on or in sleeve element.
14. The sleeve element of claim 5, wherein the main body material comprises a visco-elastic material, a degradable felt material, a sponge-like material, a gelatin, a gel, in particular a hydrogel, a polymer material, or any combination thereof.
15. The sleeve element of claim 1, wherein the sleeve element comprises a shape which is designed to not hinder a range of motion of the hip or shoulder implant after implantation, or a frustro-conical outer shape.
16. (canceled)
17. The sleeve element of claim 1, wherein the medical active agent is an analgesic or an anaesthetic.
18. The sleeve element of claim 1, wherein the sleeve element comprises two or more compartments, wherein each compartment comprises one or more medical active agents.
19. A prosthetic kit, comprising: a prosthetic hip or shoulder implant having a neck, and a sleeve element according to claim 1.
20. The prosthetic kit of claim 19, wherein an inner surface of the longitudinal channel substantially mates with an outer surface of a part of the neck on which the sleeve element is placed or will be placed.
21. The prosthetic kit of claim 19, wherein the sleeve element is designed such that it can be arranged, in the closed state, in only one position on the neck of the prosthetic hip or shoulder implant.
22. The prosthetic kit of claim 19, wherein the neck is part of a femoral component of a prosthetic hip implant, the femoral component having a neck to receive a femoral head, wherein the sleeve element is designed to be placed on the neck of the femoral component.
23. The prosthetic kit of claim 22, wherein the prosthetic hip implant further comprises an acetabular component, wherein the femoral component and acetabular component are designed to facilitate, after implantation, a range of movement of the femoral component with respect to the acetabular component, wherein outer dimensions of the sleeve element are selected to prevent that relative movement of the femoral component with respect to the acetabular component is blocked by the presence of the sleeve element on the neck of the femoral component.
24. The prosthetic kit of claim 19, wherein the prosthetic kit further comprises a loader arranged to load a sleeve element on the neck of the prosthetic hip or shoulder implant.
Description
[0089] Embodiments of the invention will now be described, by way of example only, with reference to the accompanying schematic drawings in which corresponding reference symbols indicate corresponding parts, and in which:
[0090]
[0091]
[0092]
[0093]
[0094]
[0095]
[0096]
[0097]
[0098]
[0099]
[0100]
[0101]
[0102]
[0103]
[0104]
[0105]
[0106]
[0107]
[0108]
[0109]
[0110]
[0111] The femoral component 51 comprises a stem 52 to be placed into the femur, a neck 53 and a head 54 supported on the neck 53. The acetabular component 55 comprises a acetabular cup 56 that may be provided with a liner 57 arranged in the acetabular cup 56.
[0112] Prosthetic hip implants 50 are widely known in the art. Hip replacements using these types of prosthetic hip implants 50 is currently one of the most common orthopedic operations, though patient satisfaction short- and long-term varies widely. In view of the possible negative effects of a hip replacement, such as pain and infection risks, there is a need to administer one or more medical active agents to the patient after implantation of the prosthetic hip implant 50.
[0113]
[0114] The sleeve element 1 is configured to release the medical active agent according to a predetermined release profile.
[0115] The sleeve element 1 is arranged to be completely degraded within 12 months, for example within 1 to 9 months. This relatively short degradation time has the advantage that the sleeve element 1 is only present on the neck of the prosthetic implant for a limited time.
[0116]
[0117] The sleeve element 1 comprises a longitudinal channel 2 and a longitudinal slit 3. The longitudinal channel 2 is configured to receive the neck 53. In the embodiment shown in
[0118] The longitudinal slit 3 extends over the length of the longitudinal channel 2 between the longitudinal channel 2 and an outer surface of the sleeve element 1. As a result, the sleeve element 1 comprises two longitudinal edges 4 that may be arranged against each other to create a closed ring-shaped cross section as shown in
[0119] The sleeve element 1 is elastically deformable between a closed state, as shown in
[0120] The sleeve element 1 can be brought into the opened state by moving the longitudinal edges 4 away from each other, as shown in
[0121] The advantage of this embodiment of the sleeve element 1 is that the sleeve element 1 can be arranged on the neck 53 even when the head 54 is already mounted on the neck 53. As a result, the sleeve element 1 may be arranged on the neck 53 at any suitable stage of the surgical procedure. For example, only after it has been concluded that the prosthetic hip implant 50 has been successfully implanted into a human or animal body, the sleeve element 1 may be arranged on the neck 53. The placement of the sleeve element 1 therefore does not have a large impact on the presently used surgical procedure for prosthetic hip or shoulder implants.
[0122] The inner surface of the sleeve element forming the longitudinal channel 2 may at least partially be provided with an adhesive layer that allows the sleeve element 1 to be adhered to the neck 53. This further reduces the chance that the sleeve element 1 inadvertently is moved from its position on the neck 53.
[0123] In another embodiment, the sleeve element is free of fixation elements to fixate the sleeve element 1 to the neck 53 of the prosthetic implant. Since the sleeve element 1 is elastically deformable, it may adapt its shape when it becomes pinched as a result of movements of the prosthetic implant, and therefore some displacement of the sleeve element 1 on the neck 53 may be accepted.
[0124] The sleeve element 1 is made of a biodegradable elastically deformable material and comprises a main body and a coating coated on at least a part of the surface the main body. The medical active agent is comprised in the main body. The medical active agent may be distributed substantially equally within the material of the main body. This has the advantage that a relatively large volume of medical active agent with a relatively low maximum concentration level of the medical active agent can be arranged in the main body of the sleeve element 1.
[0125] The coating comprises a coating material and the main body comprises a main body material. The coating material is stiffer than the main body material. The main body material may for example comprise a visco-elastic material, a degradable felt material, a sponge-like material, a gelatin, a gel, in particular a hydrogel, a polymer or any combination thereof. The sleeve element 1 may also be provided without a coating, i.e. only a main body of the same biodegradable elastically deformable material.
[0126] The elastic modulus of the biodegradable, elastically deformable material may be between 1 kPa and 1 MPa.
[0127] The sleeve element shown in
[0128] The outer dimensions of the sleeve element are selected such that they do not overpass a virtual line between the outer dimensions of the head mounted on the neck of a prosthesis and the outer dimensions of the base of the neck, thereby ensuring no or little interference with the range of motion of the prosthesis. Some interference may be compensated by the deformability of the material of the sleeve element 1.
[0129] To compensate any interference of the sleeve element 1 with the movement of the prosthetic implant 50, the sleeve element 1 may have a compressive strain of at least 5%, for example at least 15%, at the elastic limit of the elastically deformable material in a direction in which a compressive force is exerted on the elastically deformable material. The compressive strain may be calculated as a change in dimension in a compression direction in which a compressive force is exerted on the sleeve element divided by the original dimension of the sleeve element in the compression direction.
[0130]
[0131] In alternative embodiments, other closure devices may be provided to hold the sleeve element 1 in the closed state. These closure devices may be integrated in the material of the sleeve element 1, such as the bulges 5a and recesses 5b, but may also be provided as separate devices that can be used to hold the sleeve element 1 in the closed state. These closure devices may for example comprise closure elements such as bands, sutures, cerclages, strips, shells or covers that can be arranged around the sleeve element to hold the sleeve element 1 in the closed state. The complete sleeve element 1 including the closure device may be made of biodegradable materials.
[0132]
[0133] The elastically deformable ribs 6 may be created by a coating material coated on the inner surface of the longitudinal channel 2. The elastically deformable ribs 6 may also be created by any other suitable material. In addition, or as an alternative, elastically deformable ribs 6 may be provided in/by the material of the main body of the sleeve element 1 or on the outer side of the sleeve element. Also, other stiffening elements, such as relatively stiff partially cylindrical elements may be provided to increase the stiffness of the sleeve element 1 in order to bias the sleeve element to the closed state. The complete sleeve element, including the stiffening elements 6 may be made of biodegradable materials.
[0134]
[0135]
[0136] The adaptation of the shape and dimensions of the cross-section of the longitudinal channel 2 to substantially correspond to shape and dimensions of the cross-section of the neck 53 may also be applied in any other embodiment of a sleeve element 1, such as the sleeve elements of the embodiments shown and described in this patent application.
[0137] However, since the sleeve element 1 is made of elastically deformable material, the deformable material may also facilitate the arrangement of the sleeve element 1 on the neck of different types and sizes of the prosthetic hip or shoulder implants and facilitate the adaptation of the shape of the sleeve element 1 to the shape of the neck of the respective prosthetic hip or shoulder implant.
[0138]
[0139] For example, the first compartment 7 may comprise a medical active agent for pain treatment, such as an analgesic or anaesthetic, and the second compartment 8 may comprise an antibiotic to treat or prevent bacterial infections. These medical active agents may also be provided in a single compartment, but the use of two compartments allows to influence and control the release profiles of the two medical active agents more accurately.
[0140] In the embodiment of
[0141]
[0142]
[0143] The sleeve element 1 comprises a longitudinal slit 3 arranged between the longitudinal edges 4. The sleeve element 1 comprises a longitudinal channel 2 that tapers outwards from one side (upper side in
[0144] In the longitudinal channel 2, the sleeve element 1 comprises a relatively stiff partially cylindrical element 10. This partially cylindrical element 10 acts as a stiffening element that improves the positioning of the sleeve element 1 on the neck 53. The partially cylindrical element 10 is also part of a closure device 5. The closure device 5 comprises two extensions 11a, 11b connected at opposite ends of the partially cylindrical element 10. Each of the two extensions 11a, 11b support ratchet teeth 12a, 12b. The ratchet teeth 12a, 12b allow the extensions 11a, 11b to be locked with respect to each other in multiple relative locking positions. Each of the multiple relative locking positions relates to a specific diameter of the partially cylindrical element 10. Thus, the closure device 5 allows the sleeve element 1 to be tightly mounted on the neck 53 of different types of prosthetic hip implants even when the necks of the different types of prosthetic hip implants may have other dimensions within the range of the relative locking positions of the two extensions 11a, 11b. This tight arrangement of the partially cylindrical element 10 on the neck 53 also reduces the risk of displacement of the sleeve element 1 on the neck 53, in particular sliding over the neck 53.
[0145] The stiffness of the partially cylindrical element 10 may be selected such that the shape of the partially cylindrical element 10 may at least partially adapt to a non-cylindrical cross section of the neck 53.
[0146] All elements of the sleeve element 1 of
[0147]
[0148]
[0149] The first jaw element 102 and the second jaw element 103 are movable with respect to the main body between a normal position, shown in
[0150] The first jaw element 102 comprises a first guide surface 102a and the second jaw element 103 comprises a second guide surface 103a. By pushing the neck 53 against the first guide surface 102a and the second guide surface 103a, the first jaw element 102 and the second jaw element 103 may be moved from the normal position towards the loading position. No separate actuation mechanism is required to actuate movement of the first jaw element 102 and the second jaw element 103.
[0151]